InvestorsObserver
Sign Up Login

QLGN Qualigen Therapeutics Inc

$0.29 $0.00 (0.17%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

QLGN Stock Analysis Overview

What this means: Qualigen Therapeutics Inc (QLGN) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives QLGN a rank of 6. Our methodology considers analysis of the company's financial situation and how it has traded recently. QLGN rank of 6 means that it ranks below 94% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

QLGN Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

QLGN Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

QLGN Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

QLGN Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

QLGN Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

QLGN Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

QLGN Stock Analysis Overview

What this means: Qualigen Therapeutics Inc (QLGN) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives QLGN a rank of 6. Our methodology considers analysis of the company's financial situation and how it has traded recently. QLGN rank of 6 means that it ranks below 94% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full QLGN report

QLGN Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

QLGN Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

QLGN Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

QLGN Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

QLGN Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

QLGN Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Qualigen Therapeutics Inc (QLGN) Analyst Forecast

QLGN Price, Volume, Earnings, and Dividend Date

  • Last Price $0.29
  • Previous Close $0.29
  • Change $0.00
  • Open $0.30
  • Volume 9,216
  • Avg. Volume (100-day) 55,147
  • Market Cap 1,832,291
  • Days Range 0.2905 - 0.319
  • 52-week Range 0.28 - 1.26
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 05/21/24
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 2.314
  • PEG Ratio —

Qualigen Therapeutics Inc (QLGN) Company Description

Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.

Qualigen Therapeutics Inc (QLGN) Stock Chart

View Interactive QLGN chart

My Watchlists

Top Stocks in Biotechnology